Use of non-cryopreserved hematopoietic progenitor cells in autologous transplantation for lymphoma and multiple myeloma: a systematic review.


Authors

  • Melissa Universidad Tecnologica de Pereira https://orcid.org/0009-0000-8412-8893
  • Luz Stella Del Valle Useche Clínica San Rafael Eje Cafetero
  • Jaider Jesús Martínez Borja Universidad Tecnológica de Pereira
  • Francisco Daniel Paz Melo Fundacion universitaria San Martin, Fundación Universitaria del Area Andina
  • Yonathan Medina Valencia Universidad Sanitas
  • Diana Jhosep Lozano Alonso Institución Universitaria Visión de las Américas

DOI:

https://doi.org/10.22517/25395203.25707

Keywords:

Cryopreservation, non cryopreserved, Lymphoma, Multiple Myeloma

Abstract

Objective: To compare the effectiveness and safety of using non-cryopreservation techniques for hematopoietic progenitor precursors versus traditional cryopreservation techniques in the transplantation of autologous derivatives in patients with Lymphoma and Multiple Myeloma.

Methods: The studies that were included for this systematic review were identified by searching databases such as Scopus, Medline/Pubmed and Clinical trials, with no time limit on publication.

Results: A total of 200 published articles were obtained, of which 16 studies met the inclusion criteria. Conclusions: Autologous transplantation of hematopoietic progenitor precursors without cryopreservation is a feasible and safe alternative to consider especially in institutions with limited resources.

Downloads

Download data is not yet available.

References

Bekadja MA, Boumendil A, Blaise D. Non-cryopreserved hematopoietic stem cells in autograft patients with lymphoma: A matched-pair analysis comparing a single center experience with the use of cryopreserved stem cells reported to the European Society for Blood and Marrow Transplantation registry. Cytotherapy 2021;23(6):483-7.

Mahajan S, Tandon N, Kumar S. The evolution of stem-cell transplantation in multiple myeloma. Ther Adv Hematol 2018;9(5):123-33.

Gaytán F. Trasplante de células progenitoras hematopoyéticas en pediatría. Gac Mex Oncol 2013;12(3):174-81.

Sarmiento M, Ramírez P, Parody R, Salas MQ, Beffermann N, Jara V, et al. Advantages of non-cryopreserved autologous hematopoietic stem cell transplantation against a cryopreserved strategy. Bone Marrow Transplant 2018;53:960-6.

Philip T, Armitage JO, Spitzer G, et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin’s lymphoma. N Engl J Med 1987;316:1493-8.

Philip T, Guglielmi C, Hagenbeek A, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma. N Engl J Med 1995;333:1540-5.

Reich-Slotky R, Vasovic LV, Land KJ, Halpenny M, Woeltz J, Mathew AJ, et al. Cryopreserved hematopoietic stem/progenitor cells stability program-development, current status and recommendations: A brief report from the AABB-ISCT joint working group cellular therapy product stability project team. Transfusion 2022;62(3):651-62.

Hahn S, Sireis W, Hourfar K, et al. Effects of storage temperature on hematopoietic stability and microbial safety of BM aspirates. Bone Marrow Transplant 2014;49(3):338-48.

Ramzi M, Zakerinia M, Nourani H, Dehghani M, Vojdani R, Haghighinejad H. Non-cryopreserved hematopoietic stem cell transplantation in multiple myeloma: A single center experience. Clin Transplant 2012;26:117-22.

Piriyakhuntorn P, Tantiworawit A, Rattanathammethee T, Hantrakool S, Chai-Adisaksopha C, Rattarittamrong E, et al. Outcomes of non-cryopreserved versus cryopreserved peripheral blood stem cells for autologous stem cell transplantation in multiple myeloma. Ann Transplant 2020;25:e927084.

Ruiz-Argüelles GJ, Ruiz-Argüelles A, Pérez-Romano B, Marín-López A, Delgado-Lamas JL. Non-cryopreserved peripheral blood stem cells autotransplants for hematological malignancies can be performed entirely on an outpatient basis. Am J Hematol. 1998 Jul;58(3):161-4.

Noiperm P, Julamanee J, Viboonjuntra P, Lekhakula A. Non-cryopreserved peripheral blood stem cell graft for autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma patients. Ann Transplant. 2023 Jan 17;28:e938595.

Ruiz-Argüelles GJ, Gómez-Rangel D, Ruiz-Delgado GJ, Ruiz-Argüelles A, Pérez-Romano B, Rivadeneyra L. Results of an autologous noncryopreserved, unmanipulated peripheral blood hematopoietic stem cell transplant program: a single-institution, 10-year experience. Acta Haematol. 2023;110(4):179-83.

Voloshin SV, Garifullin AD, Kuzyaeva AA, Sinitsina NN, Alekseeva NN, Schmidt AV, Linnikov SY, Shuvaev VA, Kuvshinov AY, Potikhonova NA, Seltser AV, Balashova VA, Chubukina ZV, Bogdanov AN, Sidorkevich SV. The use of non-cryopreserved hematopoietic stem cells for autologous transplantation in multiple myeloma patients. Oncohematology. 2022;17(2):82-94. (In Russ.)

Kardduss-Urueta A, Gale RP, Gutierrez-Aguirre CH, Herrera-Rojas MA, Murrieta-Álvarez I, Perez-Fontalvo R, et al. Freezing the graft is not necessary for autotransplants for plasma cell myeloma and lymphomas. Bone Marrow Transplant. 2018.

Kayal S, Sharma A, Iqbal S, Tejomurtula T, Cyriac SL, Raina V. High dose chemotherapy and autologous stem cell transplantation in multiple myeloma: a single institution experience at All India Institute of Medical Sciences, New Delhi, using non-cryopreserved peripheral blood stem cells. Clin Lymphoma Myeloma Leuk. 2014;14:140-7.

Saika K, Gatellier L. Age-specific lymphoma incidence rate in the world. Jpn J Clin Oncol. 2021;51(10):1599-1600.

Jennane S, Hasnaoui N, Mahtat EM, Merimi F, Bougar S, El Maaroufi H, Belmekki A, Zafad S, Essakalli M, Mikdame M, Doghmi K. Non-cryopreserved peripheral blood stem cells autologous transplantation in multiple myeloma: bicentric study. Transfus Clin Biol. 2020 Aug;27(3):152-6.

Naithani R, Dayal N, Pathak S, Rai R. Hematopoietic stem cell transplantation using non-cryopreserved peripheral blood stem cells graft is effective in multiple myeloma and lymphoma. Bone Marrow Transplant. 2018 Sep;53(9):1198-1200.

Kulkarni U, Devasia AJ, Korula A, Fouzia NA, Nisham PN, Samoon YJ, Lakshmi KM, Abraham A, Srivastava A, Mathews V, George B. Use of non-cryopreserved peripheral blood stem cells is associated with adequate engraftment in patients with multiple myeloma undergoing an autologous transplant. Biol Blood Marrow Transplant. 2018 Dec;24(12):e31-e5.

Ruiz-Argüelles GJ, Lobato-Mendizábal E, Ruiz-Argüelles A, Pérez-Romano B, Arizpe-Bravo D, Marín-López A. Non-cryopreserved unmanipulated hematopoietic peripheral blood stem cell autotransplant program: long-term results. Arch Med Res. 1999 Sep-Oct;30(5):380-4.

Curado MP, Oliveira MM, Silva DR, Souza DLB. Epidemiology of multiple myeloma in 17 Latin American countries: an update. Cancer Med. 2018;7(5):2101-8.

Cuellar-Ambrosi F, Karduss UA, Gomez WR, et al. Hematologic reconstitution following high-dose and supralethal chemoradiotherapy using stored, noncryopreserved autologous hematopoietic stem cells. Transplant Proc. 2004;36:1704-5.

Mabed M, Shamaa S. High-dose chemotherapy plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed Hodgkin disease. Biol Blood Marrow Transplant. 2006;12:942-8.4o mini

Downloads

Published

2025-06-05

How to Cite

Melissa, Del Valle Useche , L. S. ., Martínez Borja , J. J. ., Paz Melo, F. D. . ., Medina Valencia , Y. ., & Lozano Alonso , D. J. . (2025). Use of non-cryopreserved hematopoietic progenitor cells in autologous transplantation for lymphoma and multiple myeloma: a systematic review. Revista Médica De Risaralda, 31(1), 131–145. https://doi.org/10.22517/25395203.25707

Issue

Vol. 31 No. 1 (2025): Enero-junio 2025

Section

Scoping Review

License

Cesión de derechos y tratamiento de datos

La aceptación de un artículo para su publicación en la Revista Médica de Risaralda implica la cesión de los derechos de impresión y reproducción, por cualquier forma y medio, del autor a favor de  Facultad de Ciencias de la Salud de la Universidad Tecnológica de Pereira. 1995-2018. Todos los derechos reservados ®

por parte de los autores para obtener el permiso de reproducción de sus contribuciones. La reproducción total o parcial de los trabajos aparecidos en la Revista Médica de Risaralda, debe hacerse citando la procedencia, en caso contrario, se viola los derechos reservados.

Asimismo, se entiende que los conceptos y opiniones expresados en cada trabajo son de la exclusiva responsabilidad del autor, sin responsabilizarse ni solidarizarse, necesariamente, ni la redacción, ni la editorial.

Es responsabilidad de los autores poder proporcionar a los lectores interesados copias de los datos en bruto, manuales de procedimiento, puntuaciones y, en general, material experimental relevante.

Asimismo, la Dirección de la revista garantiza el adecuado tratamiento de los datos de carácter personal